Hongliang Yao1, Zhulin Yang, Yongguo Li. 1. Department of General Surgery, Second Xiangya Hospital, Central South University, Changsha 410011, China.
Abstract
OBJECTIVE: To determine the expressive level of checkpoint kinase 1 (CHK1) and polo-like kinase 1 (PLK1) and to detect their clinicopathological significance in benign and malignant lesions of the stomach. METHODS: Envision Tm immunohistochemistry was used to detect the expression level of CHK1 and PLK1 in conventional paraffin-embedded sections from specimens of primary foci (n=59)and metastatic foci of lymph node (n=42) of gastric cancer, peritumoral tissues (n=20), and benign lesions of the stomach (n=95). RESULTS: The positive rates of CHK1 were significantly higher in gastric cancer than that in different types of benign lesions(P<0.01). The positive rates of PLK1 were significantly higher in gastric cancer than that in peritumoral tissues (P<0.05) and different types of benign lesions (P<0.01), and the positive cases of PLK1 in benign lesion showed atypical hyperplasia. No significant difference of CHK1 and PLK1 expression was found between metastatic foci and corresponding primary foci (P>0.05). The positive rates of CHK1 and PLK1 were significantly lower in the non-metastatic lymph node than that in the metastatic lymph node (P<0.05). The positive rate of CHK1 was significantly lower in histologic grade II than that in the histologic grade III+IV (P<0.05). Positive correlation was found between the expression of CHK1 and PLK1 in gastric cancer tissues (P<0.01). CONCLUSION: The expression level of CHK1 and /or PLK1 might be important biological markers of kinases to reflect the carcinogenesis, progression, biological behaviors, and guide clinical auxiliary treatment of gastric cancer.
OBJECTIVE: To determine the expressive level of checkpoint kinase 1 (CHK1) and polo-like kinase 1 (PLK1) and to detect their clinicopathological significance in benign and malignant lesions of the stomach. METHODS: Envision Tm immunohistochemistry was used to detect the expression level of CHK1 and PLK1 in conventional paraffin-embedded sections from specimens of primary foci (n=59)and metastatic foci of lymph node (n=42) of gastric cancer, peritumoral tissues (n=20), and benign lesions of the stomach (n=95). RESULTS: The positive rates of CHK1 were significantly higher in gastric cancer than that in different types of benign lesions(P<0.01). The positive rates of PLK1 were significantly higher in gastric cancer than that in peritumoral tissues (P<0.05) and different types of benign lesions (P<0.01), and the positive cases of PLK1 in benign lesion showed atypical hyperplasia. No significant difference of CHK1 and PLK1 expression was found between metastatic foci and corresponding primary foci (P>0.05). The positive rates of CHK1 and PLK1 were significantly lower in the non-metastatic lymph node than that in the metastatic lymph node (P<0.05). The positive rate of CHK1 was significantly lower in histologic grade II than that in the histologic grade III+IV (P<0.05). Positive correlation was found between the expression of CHK1 and PLK1 in gastric cancer tissues (P<0.01). CONCLUSION: The expression level of CHK1 and /or PLK1 might be important biological markers of kinases to reflect the carcinogenesis, progression, biological behaviors, and guide clinical auxiliary treatment of gastric cancer.
Authors: Svetlana Grabauskiene; Edward J Bergeron; Guoan Chen; Dafydd G Thomas; Thomas J Giordano; David G Beer; Meredith A Morgan; Rishindra M Reddy Journal: J Surg Res Date: 2013-12-18 Impact factor: 2.192
Authors: Henry Okuchukwu Ebili; Victoria O Iyawe; Kikelomo Rachel Adeleke; Babatunde Abayomi Salami; Adekunbiola Aina Banjo; Chris Nolan; Emad Rakha; Ian Ellis; Andrew Green; Ayodeji Olayinka Johnson Agboola Journal: Mol Diagn Ther Date: 2018-02 Impact factor: 4.074
Authors: J Bargiela-Iparraguirre; L Prado-Marchal; M Fernandez-Fuente; A Gutierrez-González; J Moreno-Rubio; M Muñoz-Fernandez; M Sereno; R Sanchez-Prieto; R Perona; I Sanchez-Perez Journal: Sci Rep Date: 2016-02-12 Impact factor: 4.379
Authors: Zhihui Wang; Mette S Førsund; Claes G Trope; Jahn M Nesland; Ruth Holm; Ana Slipicevic Journal: Cancer Med Date: 2018-07-02 Impact factor: 4.452